These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31536382)

  • 21. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
    Deng J; Tang J; Wang G; Zhu YS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of MUC1 in prostate cancer metastasis and CRPC development.
    Wong N; Major P; Kapoor A; Wei F; Yan J; Aziz T; Zheng M; Jayasekera D; Cutz JC; Chow MJ; Tang D
    Oncotarget; 2016 Dec; 7(50):83115-83133. PubMed ID: 27825118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
    Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
    Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
    Das R; Feng FY; Selth LA
    Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
    Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
    Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient derived organoids to model rare prostate cancer phenotypes.
    Puca L; Bareja R; Prandi D; Shaw R; Benelli M; Karthaus WR; Hess J; Sigouros M; Donoghue A; Kossai M; Gao D; Cyrta J; Sailer V; Vosoughi A; Pauli C; Churakova Y; Cheung C; Deonarine LD; McNary TJ; Rosati R; Tagawa ST; Nanus DM; Mosquera JM; Sawyers CL; Chen Y; Inghirami G; Rao RA; Grandori C; Elemento O; Sboner A; Demichelis F; Rubin MA; Beltran H
    Nat Commun; 2018 Jun; 9(1):2404. PubMed ID: 29921838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer.
    Alahari SV; Eastlack SC; Alahari SK
    Int Rev Cell Mol Biol; 2016; 324():229-54. PubMed ID: 27017010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression.
    Ifere GO; Ananaba GA
    Recent Pat DNA Gene Seq; 2009; 3(3):151-63. PubMed ID: 19891595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering the function of non-coding RNAs in prostate cancer.
    Ramalho-Carvalho J; Fromm B; Henrique R; Jerónimo C
    Cancer Metastasis Rev; 2016 Jun; 35(2):235-62. PubMed ID: 27221068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
    Chua MLK; Lo W; Pintilie M; Murgic J; Lalonde E; Bhandari V; Mahamud O; Gopalan A; Kweldam CF; van Leenders GJLH; Verhoef EI; Hoogland AM; Livingstone J; Berlin A; Dal Pra A; Meng A; Zhang J; Orain M; Picard V; Hovington H; Bergeron A; Lacombe L; Fradet Y; Têtu B; Reuter VE; Fleshner N; Fraser M; Boutros PC; van der Kwast TH; Bristow RG
    Eur Urol; 2017 Nov; 72(5):665-674. PubMed ID: 28511883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the lethal variant of prostate cancer: power of examining extremes.
    Aparicio A; Logothetis CJ; Maity SN
    Cancer Discov; 2011 Nov; 1(6):466-8. PubMed ID: 22586648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.
    Hua J; Lu J; Isaev K; Soares F; Guo H; Ahmed M; He HH
    Per Med; 2017 Mar; 14(2):159-169. PubMed ID: 29754555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
    Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM
    Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of lncRNAs in prostate cancer development and progression.
    Weiss M; Plass C; Gerhauser C
    Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer: Risk SNPs modulate lncRNAs.
    Stone L
    Nat Rev Urol; 2016 Oct; 13(10):565. PubMed ID: 27578041
    [No Abstract]   [Full Text] [Related]  

  • 40. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
    Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
    Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.